![]() ![]() This research will investigate whether one drug or the combination of the two has any effect on memory problems associated with AD. ![]() These two drugs have never been tested as a combination treatment for AD and the use of these drugs, either alone or in combination, is not approved by the FDA for the treatment of AD. Both of these drugs are approved by the FDA for use in the treatment of asthma and inflammation, respectively. Cromolyn sodium is taken using a mouth inhaler device (similar to those used in the treatment of asthma) once a day, and ibuprofen is taken orally (by mouth) as a tablet once a day. The clinical research study AZT-001 is being conducted to assess whether to test the effects of two drugs on memory - cromolyn sodium and ibuprofen - in people with clinical signs and symptoms of early Alzheimer’s disease (AD). This study is sponsored by AZTherapies, Inc. Learn more about the NKI Rockland Sample project at .Ĭall (845) 398-2666 or email Kline Institute 35 Third Ave (off Old Orangeburg Rd.) Orangeburg, NY 10962 Reservations are recommended for all events.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |